Ingevity Corporation
NGVT
$52.23
$0.060.12%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 333.10M | 295.40M | 284.00M | 298.80M | 333.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 333.10M | 295.40M | 284.00M | 298.80M | 333.80M |
| Cost of Revenue | 199.20M | 169.00M | 170.60M | 190.60M | 198.40M |
| Gross Profit | 133.90M | 126.40M | 113.40M | 108.20M | 135.40M |
| SG&A Expenses | 44.10M | 42.40M | 43.10M | 39.30M | 37.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 250.30M | 217.70M | 221.40M | 237.20M | 242.50M |
| Operating Income | 82.80M | 77.70M | 62.60M | 61.60M | 91.30M |
| Income Before Tax | 62.20M | -125.70M | 26.80M | 8.80M | 54.00M |
| Income Tax Expenses | 21.40M | 7.10M | 6.30M | -7.80M | 6.50M |
| Earnings from Continuing Operations | 40.80M | -132.80M | 20.50M | 16.60M | 47.50M |
| Earnings from Discontinued Operations | 2.70M | -- | -- | -- | -154.70M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 43.50M | -146.50M | 20.50M | 16.60M | -107.20M |
| EBIT | 82.80M | 77.70M | 62.60M | 61.60M | 91.30M |
| EBITDA | 108.40M | 100.90M | 85.10M | 94.30M | 117.50M |
| EPS Basic | 1.20 | -4.02 | 0.56 | 0.46 | -2.95 |
| Normalized Basic EPS | 1.11 | 1.00 | 0.69 | 0.63 | 1.19 |
| EPS Diluted | 1.17 | -4.02 | 0.56 | 0.45 | -2.94 |
| Normalized Diluted EPS | 1.09 | 1.01 | 0.69 | 0.63 | 1.19 |
| Average Basic Shares Outstanding | 36.31M | 36.42M | 36.38M | 36.30M | 36.35M |
| Average Diluted Shares Outstanding | 36.96M | 36.42M | 36.66M | 36.60M | 36.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |